References
- Murray N, Coy P, Pater J. The importance of timing for thoracic irradiation (TI) in the combined modality treatment of limited stage small cell lung cancer (LSCLC) (abstr). Proc Am Soc Clin Oncol 1991; 10: 243
- Murray N, Shah A, Osoba D. Intensive weekly chemotherapy for the treatmeit of extensive stage small cell lung cancer. J Clin Oncol 1991; 9: 1672
- Miles D, Harper P, Earl H. Intensive weekly chemotherapy for good prognosis patients with small cell lung cancer (SCLC) (abstr). Proc Am Soc Clin Oncol 1989; 8225
- Masuda M, Fukuoka M, Negoro N. CODE chemotherapy with or without recombinant human granulocyte colony-stimulating factor (rh G-CSF) in extensive-stage (ES) small cell lung cancer (SCLC) (abstr). Proc Am Soc Clin Oncol 1991; 10: 254
- Klimo P, Connors J M. MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann Int Med 1985; 102: 596–602
- Murray N, Osoba D, Shah A. Brief Intensive chemotherapy for metastatic non-small-cell lung cancer: a phase II study of the weekly CODE regimen. J Natl Cancer Inst 1991; 83: 190–194